Cysteine and serine proteases of synovial tissue in rheumatoid arthritis and osteoarthritis

Scandinavian Journal of Rheumatology

Volumn 36, Issue 5, 2007, Pages 373-377

  Solau Gervais, E ^a,c   Zerimech, F ^a   Lemaire, R ^b   Fontaine, C ^a   Huet, G ^a   Flipo, R M ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Arthritis Center   (United States)

^c POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CATHEPSIN B; CATHEPSIN L; CYSTEINE; DIPEPTIDYL PEPTIDASE IV; SERINE PROTEINASE;

ADULT; ARTHRODESIS; ARTICLE; CENTRIFUGAL ANALYZER; CONTROLLED STUDY; DISEASE DURATION; ENZYME ACTIVITY; FEMALE; HUMAN; JOINT INJURY; JOINT PROSTHESIS; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SURGICAL TECHNIQUE; SYNOVECTOMY; SYNOVIUM;

ADULT; AGE FACTORS; AGED; ANTIGENS, CD26; ARTHRITIS, RHEUMATOID; CALPAIN; CATHEPSIN B; CATHEPSINS; CYSTEINE ENDOPEPTIDASES; FEMALE; HUMANS; KINETICS; MALE; MIDDLE AGED; OSTEOARTHRITIS; SYNOVIAL MEMBRANE;

EID: 35648962500     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740701340172     Document Type: Article

References (36)

1. Vaes G. Cartilage and bone tissue damage in arthritis: cellular co-operation and enzymatic mechanisms. Scand J Rheumatol Suppl 1981;40:65-71.
2. Cha HS, Kim TJ, Kim JY, Lee MH, Jeon CH, Kim J, et al. Autoantibodies to glucose-6-phosphate isomerase are elevated in the synovial fluid of rheumatoid arthritis patients. Scand J Rheumatol 2004;33:179-84.
3. Gysen P, Malaise M, Gaspar S, Franchimont P. Measurement of proteoglycans, elastase, collagenase and protein in synovial fluid in inflammatory and degenerative arthropathies. Clin Rheumatol 1985;4:39-50.
4. Walakovits LA, Moore VL, Bhardwaj N, Gallick GS, Lark MW. Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. Arthritis Rheum 1992;35:35-42.
5. Virca GD, Mallya RK, Pepys MB, Schnebli HP. Quantitation of human leukocyte elastase, cathepsin G, alpha-2-macroglobulin and alpha-1-proteinase inhibitor in osteoarthrosis and rheumatoid arthritis synovial fluids. Adv Exp Med Biol 1984;167:345-53.
6. Maeda S, Sawai T, Uzuli M, Takahaschi Y, Omoto H, Seki M, et al. Determination of interstitial collagenase (MMP-1) in patients with rheumatoid arthritis. Ann Rheum Dis 1995;54:970-5.
7. Lenarcic B, Gabrijelcic D, Rozman B, Drobnic-Kosorok M, Turk V. Human cathepsin B and cysteine proteinase inhibitors (CPIs) in inflammatory and metabolic joint diseases. Biol Chem Hoppe Seyler 1988;369(Suppl):257-61.
8. Maciewicz RA, Etherington DJ. Enzyme immunoassay for cathepsins B and L in synovial fluids from patients with arthritis. Biochem Soc Trans 1988;16:812-13.
9. Fukui I, Tanaka K, Murachi T. Extracellular appearance of calpain and calpastatin in the synovial fluid of the knee joint. Biochem Biophys Res Commun 1989;162:559-66.
10. Gotoh H, Hagihara M, Nagatsu T, Iwata H, Miura T. Activities of dipeptidyl peptidase II and dipeptidyl peptidase IV in synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Clin Chem 1989;35:1016-18.
11. Maciewicz RA, Wotton SF, Etherington DJ, Duance VC. Susceptibility of the cartilage collagens types II, IX and XI to degradation by the cysteine proteinases, cathepsins B and L. FEBS Lett 1990;269:189-93.
12. Huet G, Flipo RM, Richet C, Thiebaut C, Demeyer D, Balduyck M, et al. Measurement of elastase and cysteine proteinases in synovial fluid of patients with rheumatoid arthritis, sero-negative spondylarthropathies, and osteoarthritis. Clin Chem 1992;38:1694-7.
13. Lemaire R, Huet G, Zerimech F, Grard G, Fontaine C, Duquesnoy B, et al. Selective induction of the secretion of cathepsins B and L by cytokines in synovial fibroblast-like cells. Br J Rheumatol 1997;36:735-43.
14. Muller-Ladner U, Kriegsmann J, Gay RE, Koopman WJ, Gay S, Chatham WW. Progressive joint destruction in a human immunodeficiency virus-infected patient with rheumatoid arthritis. Arthritis Rheum 1995;38:1328-32.
15. Keyszer GM, Heer AH, Kriegsmann J, Geiler T, Trabandt A, Keysser M, et al. Comparative analysis of cathepsin L, cathepsin D, and collagenase messenger RNA expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis, by in situ hybridization. Arthritis Rheum 1995;38:976-84.
16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
17. Zerimech F, Huet G, Balduyck M, Degand P. Cysteine proteinase activity in synovial fluids measured with a centrifugal analyzer. Clin Chem 1993;39:1751-3.
18. Shimizu K, Hamamoto T, Hamakubo T, Lee WJ, Suzuki K, Nakagawa Y, et al. Immunohistochemical and biochemical demonstration of calcium-dependent cysteine proteinase (calpain) in calcifying cartilage of rats. J Orthop Res 1991;9:26-36.
19. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Proteins measurement with folin phenol reagent. J Biol Chem 1951;193:265-75.
20. Trabandt A, Gay RE, Fassbender HG, Gay S. Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis. Arthritis Rheum 1991;34:1444-51.
21. Keyszer G, Redlich A, Haupl T, Zacher J, Sparmann M, Engethum U, et al. Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis: a parallel investigation by semiquantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry. Arthritis Rheum 1998;41:1378-87.
22. Lemaire R, Flipo RM, Migaud H, Fontaine C, Huet G, Dacquembronne E, et al. Alternative splicing of the 5′ region of cathepsin B pre-messenger RNA in rheumatoid synovial tissue. Arthritis Rheum 1997;40:1540-2.
23. Biroc SL, Gay S, Hummel KM, Palmer J, Spencer D, Sa S, et al. Cysteine protease activity is up-regulated in joints of rats with adjuvant induced arthritis. Arthritis Rheum 1997;40:S98.
24. Cunnane G, FitzGerald O, Hummel KM, Gay RE, Gay S, Bresnihan B. Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis. Rheumatology 1999;38:34-42.
25. Hashimoto Y, Kakegawa H, Narita Y, Hachiya Y, Hayakawa T, Kos J, et al. Significance of cathepsin B accumulation in synovial fluid of rheumatoid arthritis. Biochem Biophys Res Commun 2001;283:334-9.
26. Yamamoto S, Shimizu K, Suzuki K, Nakagawa Y, Yamamuro T. Calcium-dependent cysteine proteinase (calpain) in human arthritic synovial joints. Arthritis Rheum 1992;35:1309-17.
27. Hegen M, Niedobitek G, Klein CE, Stein H, Fleischer B. The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity. J Immunol 1990;144:2908-14.
28. Lapadula G, Iannone F, Zuccaro C, Covelli M, Patella V, Lobianco G, et al. Expression of membrane-bound peptidases (CD10 and CD26) on human articular chondrocytes. Possible role of neuropeptidases in the pathogenesis of osteoarthritis. Clin Exp Rheumatol 1995;13:143-8.
29. Fleischer B. CD26: a surface protease involved in T-cell activation. Immunol Today 1994;15:180-4.
30. Kamori M, Hagihara M, Nagatsu T, Iwata H, Miura T. Activities of dipeptidyl peptidase IV, prolyl endopeptidase, and collagenase-like peptidase in synovial membrane for patients with rheumatoid arthritis and osteoarthritis. Biochem Med Metab Biol 1991;45:154-60.
31. Gerli R, Muscat C, Bertotto A, Bistoni O, Agea E, Tognellini R, et al. CD26 surface molecule involvement in T cell activation and lymphokine synthesis in rheumatoid and other inflammatory synovitis. Clin Immunol Immunopathol 1996;80:31-7.
32. Mizokami A, Eguchi K, Kawakami A, Ida H, Kawabe Y, Tsukada T, et al. Increased population of high fluorescence 1F7 (CD26) antigen on T cells in synovial fluid of patients with rheumatoid arthritis. J Rheumatol 1996;23:2022-6.
33. Muscat C, Bertotto A, Agea E, Bistoni O, Ercolani R, Tognellini R, et al. Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients. Clin Exp Immunol 1994;98:252-6.
34. Ahmed NK, Martin LA, Watts LM, Palmer J, Thornburg L, Prior J, et al. Peptidyl fluoromethyl ketones as inhibitors of cathepsin B. Implication for treatment of rheumatoid arthritis. Biochem Pharmacol 1992;44:1201-7.
35. Tanaka S, Murakami T, Horikawa H, Sugiura M, Kawashima K, Sugita T. Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV. Int J Immunopharmacol 1997;19:15-24.
36. Yoshifuji H, Umehara H, Maruyama H, Itoh M, Tanaka M, Kawabata D, et al. Amelioration of experimental arthritis by a calpain-inhibitory compound: regulation of cytokine production by E-64-d in vivo and in vitro. Int Immunol 2005;17:1327-6.